CD40ligand‐expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo†Maria A. González-Carmona, Volker Schmitz, Yildiz Yildiz et al.|Hepatology|2008Cited by 67
Improving immunotherapy of hepatocellular carcinoma (<scp>HCC</scp>) using dendritic cells (<scp>DC</scp>) engineered to express <scp>IL</scp>‐12 <i>in vivo</i>Annabelle Vogt, Maria A. González-Carmona, Elisabeth Sievers et al.|Liver International|2013Cited by 30
539 DENDRITIC CELLS ENGINEERED TO EXPRESS CD40L AND AFP INDUCE TUMOR REGRESSION OF SUBCUTANEOUS HEPATOCELLULAR TUMORS BY ACTIVATING INNATE AND ADAPTIVE IMMUNITY AND BY INDUCING APOPTOSISMaria A. González-Carmona, Wolfgang H. Caselmann, Tilman Sauerbruch et al.|Journal of Hepatology|2008Cited by 0